… This review will address updates in lung cancer … clinical studies and their prognosis. The
International Association for the Study of Lung Cancer (IASLC) has developed the lung cancer …

… In this review, we present an overview regarding updates on the genetic landscape,
current standard of care, as well as recently FDA-approved therapeutic strategies in SCLC. …

… cell lung cancer (… clinical trials with these tyrosine kinase inhibitors, with a focus on erlotinib,
as first-line treatment towards a form of personalized medicine aimed at improving clinical …

For the use of immunotherapy in metastatic non–small cell lung cancer (NSCLC), the NCCN
Guidelines for NSCLC reflect the importance of assessing levels of PD-L1 expression to …

… -related deaths in Europe for 2017 is estimated to represent the leading cause of cancer …
cell lung cancer (NSCLC) accounts for 80%–90% of lung cancers, while small cell lung cancer (…

… In this review, we generalized the latest updates on MPLC from definition, etiology and
epidemiology, clinical management, and genomic updates. We summarized the different …

… article is to provide updated recommendations for the treatment of patients with stage IV
non–small-cell lung cancer. A literature … An Update Committee reviewed the literature and made …

… The purpose of this guideline update is to revise the American Society of Clinical Oncology
(… IV non–small-cell lung cancer (NSCLC). The full ASCO clinical practice guideline update on …

… update is to revise the ASCO guideline on the systemic treatment of patients with stage IV
non–small-cell lung cancer (… An Expert Panel was convened to develop updated clinical …

… The general background information on lung cancer provided in … Lung cancer is divided
into two major histologic types: non-small cell lung cancer (NSCLC) and small cell lung cancer. …